FK-506 in experimental renal allografts.
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced; D004285:Dogs; D006085:Graft Survival / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation; D010215:Papio; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use; D016559:Tacrolimus; D014657:Vasculitis / Q000139:chemically induced
D007166:Immunosuppressive Agents; D011725:Pyridines; D016559:Tacrolimus